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Abstract
Aim The enumeration of intraepithelial lymphocytes sub-
sets (total, cd, and CD3– IELs) by flow cytometry (FCM),
named as IEL lymphogram, constitutes a useful tool for
celiac disease (CD) diagnosis. The aim of this study was to
quantify IELs by FCM and their diagnostic value to dif-
ferentiate active, silent and potential CD.
Methods Prospective study of 60 active and 20 silent CD
patients, and 161 controls in which duodenal biopsy and
IEL quantification by FCM was performed.
Results Active and silent CD patients had significant
higher levels of both total and cd IELs than absent CD
patients (P\ 0.0001 and P\ 0.0001, P = 0.012 and
P\ 0.011; respectively). Active and silent CD patients had
significant lower levels of CD3– IELs than absent CD
patients (P\ 0.047 and P\ 0.009, respectively). More-
over, they were lower in silent than in active CD patients
(P = 0.002). Changes of IELs subsets were more marked
in children than adults active CD. The optimal IEL lym-
phogram cut off values for active CD diagnosis were: C10,
C15 and B9 %, and with better performance characteristics
for silent CD: C 11, C10 and B5 %.
Conclusion The evaluation of IELs subsets by FCM is
useful to confirm diagnosis of active and silent CD.
Keywords Intraepithelial lymphocytes  Flow cytometry 
Active celiac disease  Silent celiac disease
Introduction
Celiac disease (CD) is an autoimmune enteropathy induced
by gluten in genetically predisposed patients and charac-
terized by intestinal inflammation with lymphocytic
intraepithelial infiltration and villous atrophy [1].
Intraepithelial lymphocytes (IELs) represent an abun-
dant and heterogeneous population of antigen-experienced
T cells that reside in the intestinal epithelium. They are
composed of T cells bearing the ab (ab IELs[90 %) or
the cd T cell receptor (cd IELs\10 %). Additionally, the
epithelium of healthy intestinal mucosa contains a signifi-
cant proportion of CD3- CD103? IELs (CD3– IELs) [2].
It has been reported that IELs are increased in the
duodenal/jejunum mucosa of untreated CD patients and
would represent the earliest feature even seen when the
villous architecture is preserved. Consequently, they alone
can constitute the first sign of latent or potential forms of
CD [3–6]. However, it can also be found in other
autoimmune disorders, viral infections and diverse gas-
trointestinal diseases, such as small intestinal bacterial
overgrowth (SIBO), tropical sprue, microscopic colitis,
inflammatory bowel disease, irritable bowel syndrome
(IBS) and allergic enteritis. Therefore, increased IELs are
considered a hallmark of CD, although not disease-specific
[2, 7].
Besides, increased cd IELs can be found in the intestinal
epithelium of both treated and untreated CD patients, and
they are considered highly sensitive and specific for all the
forms of CD. However, they are not pathognomonic,
because they are also found in cow milk-sensitive
enteropathy, food allergy, Crohn’s disease, post-enteritis
syndrome, cryptosporidiasis and IgA-deficiency [8–11]. On
the other hand, CD3- IELs are present in healthy duodenal
mucosa and disappear in active CD [12–15]. Therefore,
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quantification of both cd and CD3– IELs confers specificity
to the finding of increased IELs observed in CD patients
[12, 16]. Thus, the enumeration of IELs and the
immunophenotyping of IELs subsets (total, cd, and CD3-
IELs) by flow cytometry (FCM), named IEL lymphogram,
constitute useful diagnostic tools for CD diagnosis but also
to evaluate the activity of the disease and to identify
atypical (latent and potential CD) and even asymptomatic
forms (silent CD) [6].
The aim of this prospective study was to evaluate the
diagnostic performance of quantifying the IELs subsets
(total, cd, and CD3- IELs) by FCM in patients with active
and silent CD, and to study differences between children and
adults with active CD from a referral university hospital.
Methods
This prospective study involved 231 patients with clinical
suspicion for CD who underwent a duodenal biopsy and
serologic studies for CD at the Pediatrics and the Gas-
troenterology outpatient clinics at the ‘‘Hospital Universi-
tario Marques de Valdecilla’’ between June 2008 and April
2012. The work has been carried out in accordance with the
local Ethics Committee. Clinical and histological data were
collected from information contained in medical records.
We subdivided patients according to the type of CD into
the following groups: active CD (n = 60) and silent CD
(n = 20). We have also included 161 patients without CD
(absent CD) in whom biopsy and serum tests were per-
formed, as control group.
The diagnosis of CD was based on ESPGHAN and AGA
criteria. The diagnosis of active CD required the presence
of the classical symptoms of malabsorption, positive
serology [anti-recombinant human tissue transglutaminase
(TTG) and anti-gliadin (AGA, whole gliadin extract) IgA
or IgG antibodies], as well as compatible histopathology
and HLA-DQ2 and/or -DQ8. The diagnosis of silent CD
was made in asymptomatic patients (with positive serology
and villous atrophy).
The combined study of total, cd, and CD3- IELs, ter-
med IEL lymphogram, was performed by FCM in all
patients. A single biopsy specimen was obtained for FCM
analysis at the same time of diagnostic endoscopy for
histological analysis. The sample was kept in physiologic
saline solution, and immediately processed using a previ-
ously described protocol with minor modifications [17].
Briefly, IEL and epithelial cells were liberated from the
mucosal specimens by mechanical disaggregation. The
suspension of released cells was collected by centrifuga-
tion, washed and surface labelled with the appropriate
fluorochrome-conjugated monoclonal antibodies (mAbs):
CD45-PerCP, CD3-FITC, TcRc d-PE and CD103-PE (BD
Biosciences, San Diego, CA). Data were acquired in a
FACSCalibur (BD Biosciences) and analyzed with Cell
Quest software (BD Biosciences). IEL cells were selected
from the entire cell population of epithelial cells after
gating on the basis of their low side scattering and CD45
expression (Fig. 1).
Duodenal biopsies were categorized according to Marsh
classification as modified by Oberhuber et al. [14]. Lesions
were further divided into two categories: mild, including
increased intraepithelial lymphocytes, crypt hyperplasia, or
mild villous atrophy (Marsh I, II, and IIIa); and severe, with
marked villous atrophy, subtotal and total (Marsh IIIb and IIIc).
Statistical analysis
Statistical analysis was carried out with the use of SPSS
software (version 13, SPSS, Chicago, IL). All data were
expressed as median ± interquartile range (IQR).
Differences in the percentage of the three IELs subsets
(total, cd and CD3-) among the different groups of CD and
between children and adults active CD patients were cal-
culated by the Mann–Withney U non-parametric test. This
test was also used to calculate differences in the degree of
histopathological lesions between the different groups of
CD and between children and adults active CD.
The correlation among serum autoantibodies and total,
cd and CD3- IELs frequencies in active and silent CD
patients were calculated by the Spearman rho test. P values
\0.05 were considered significant.
A receiver operator characteristic (ROC) curve analysis
associated with the Youden index was carried out to
determine the optimal cut off (CO) values for the combi-
nation of total, cd and CD3- IELs counts (IEL lym-
phogram) that could be used for the diagnosis of active,
silent and potential CD. Diagnostic capacity was consid-
ered failed when area under the ROC curves (AUC) results
Fig. 1 Selection of total IELs respect to the total cellularity of the
duodenal epithelium, on the basis of their low 90 light scattering and
CD45 expression
14 Page 2 of 7 Autoimmun Highlights (2016) 7:14
123
were\0.5. The diagnostic value of IEL lymphogram was
calculated as sensitivity, specificity, positive predictive
value (PPV) and negative predictive value (NPV).
Results
Patient characteristics
The general characteristics of the patients included in the
study are summarized in the Table 1. Among the 60
patients with active CD, 49 were children (82 %, fema-
le/male ratio = 1.6:1) and 11 were adults (18 %, female/-
male ratio = 4.5:1). However, from the patients with silent
and absent CD, 3 out of 20 (15 %, female/male
ratio = 2:1), and 11 out of 161 (7 %, female/male
ratio = 1.6:1) were children, respectively.
IELs subsets counts in the different types of celiac
disease
The median percentage of total IELs was significantly
higher in both active CD and silent CD patients than in
patients with absent CD. No significant differences were
found among active and silent CD patients (Fig. 2a).
The median percentage of cd IELs was also significantly
higher in both active CD and silent CD patients than in
patients with absent CD. No significant differences were
found among active and silent CD patients (Fig. 2b).
The mean percentage of CD3- IELs was significantly
lower in both active CD and silent CD than in patients with
absent CD. Moreover, it was significantly lower in silent
CD than in active CD (Fig. 2c).
IELs subsets counts in children and adult active
celiac disease
Children had more total and cd IELs (18 ± 22 and
27 ± 19 %, respectively) than adult active CD patients
(11 ± 22 and 15.5 ± 14.5 %, respectively), although no sig-
nificant differences were found among the groups (P = 0.176
and P = 0.088, respectively). On the contrary, the counts of
CD3- IELs were significantly lower in adult than in children
active CD patients (4 ± 7 vs. 8 ± 13 %; P = 0.008).
IELs and histopathology
The frequency of severe histopathology was significantly
higher in patients with active CD (69 %) than in silent CD
(35 %; P = 0.007). Severe active CD patients had higher
levels of total IELs, cd IELs and CD3- IELs as compared
Table 1 General characteristics of patients included in the study
n Age* Sex (male/female)
Active celiac disease 60 9 (1–63) 21/39
Silent celiac disease 20 36 (12–62) 7/13
Absent celiac disease 161 42 (5–84) 58/103
* Data are expressed as mean years (range)
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with mild active CD patients. No significant differences
were found in silent CD patients (Table 2).
IELs and serological markers
The frequency of positive AGA IgA was similar in active
(72 %) or silent CD patients (60 %), with no differences
according to patients age (Tables 3, 4). On the other hand,
the frequency of positive TTG IgA was higher in active CD
patients than in silent CD patients (87 vs. 70 %, no sig-
nificant differences).
As serum levels of TTG IgA increased, a linear ten-
dency toward higher cd IELs counts in active CD patients
(Spearman q = 0.422, P = 0.002) and more severe
histopathological lesions (Spearman q = 0.393,
P = 0.003) were observed. On the contrary, no correlation
was found in silent CD patients.
ROC curve for the IELs subsets in the diagnosis
of active and silent CD
From the ROC curve analysis performed of IEL lym-
phogram in active CD diagnosis showed that the optimal
CO values for the percentages of total, cd and CD3- IELs
were: C10 % (sensitivity = 82 % and specificity = 59 %,
AUC = 0.725), C15 % (sensitivity = 76 % and speci-
ficity = 53 %, AUC = 0.696) and B9 % (sensitiv-
ity = 67 % and specificity = 57 %, AUC = 0.614),
respectively.
The optimal CO values for the percentage of total, cd
and CD3- IELs for silent CD diagnosis were: C11 %
(sensitivity = 74 % and specificity = 60 %,
AUC = 0.673), C10 % (sensitivity = 95 % and speci-
ficity = 33 %, AUC = 0.663) and B5 % (sensitiv-
ity = 74 % and specificity = 79 %, AUC = 0.836),
respectively.
bFig. 2 a Percentage of total IELs respect to the total cellularity of the
duodenal epithelium in the study groups. Box plots with median,
quartiles and 5 and 95 percentiles. U de Mann–Whitney test was used
to detect significant differences (P\ 0.05). b Percentage of cd IELs
relative to the total number of IELs in the study groups. Box plots
show median, quartiles and 5 and 95 percentiles. U de Mann–Whitney
test was used to detect significant differences (P\ 0.05). c Percentage
of CD3– IELs relative to the total number of IELs in the study groups.
Box plots show median, quartiles and 5 and 95 percentiles. U de
Mann–Whitney test was used to detect significant differences
(P\ 0.05)
Table 2 IELs populations and
histopathology in active and
silent CD





% Total IELs 17.29 ± 14.28 25.95 ± 15.21 0.027*
% cd IELs 21.22 ± 14.28 29.44 ± 15.08 0.031*
% CD3– IELs 11.36 ± 19.57 11.62 ± 9.77 0.027*





% Total IELs 16.85 ± 7.29 14.00 ± 9.53 0.628
% cd IELs 22.54 ± 12.93 31.57 ± 19.89 0.234
% CD3– IELs 5.19 ± 6.35 2.61 ± 3.17 0.562
Data are expressed as mean ± standard deviation
CD celiac disease
* Significant differences (P\ 0.05)
a Mild histopathology: Marsh I, II, and IIIa
b Severe histopathology: Marsh grade IIIb and IIIc
Table 3 Serological markers in
celiac disease
AGA IgA?a TTG IgA?b AGA IgA? and TTG IgA?
Active celiac disease 74 (40/54) 87 (47/54) 67 (36/54)
Silent celiac disease 60 (12/20) 70 (14/20) 55 (11/20)
Absent celiac disease 1 (2/156) 0 (0/156) 0 (0/156)
Data are expressed as percentage (number of positive cases/total number of cases)
AGA IgA anti-gliadin IgA antibodies, TTG IgA anti-recombinant human tissue transglutaminase IgA
a AGA IgA? C 20 UI/L
b TTG IgA? C 4 UI/L
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ROC curve for the IELs subsets in the diagnosis
of children and adult active CD
The ROC curve analysis performed on the IEL subsets for
the children active CD diagnosis showed that the optimal
CO values for the percentage of total, cd and CD3- IELs
were: C10 % (sensitivity = 87 % and specificity = 62 %,
AUC = 0.715), C15 % (sensitivity = 82 % and speci-
ficity = 77 %, AUC = 0.832) and B9 % (sensitiv-
ity = 63 % and specificity = 61 %, AUC = 0.612),
respectively. Whereas for adult active CD patients were:
C10 % (sensitivity = 60 % and specificity = 58 %,
AUC = 0.587), C10 % (sensitivity = 90 % and speci-
ficity = 31 %, AUC = 0.547) and B4 % (sensitiv-
ity = 64 % and specificity = 80 %, AUC = 0.798),
respectively.
Diagnostic value of IEL lymphogram for active
and silent CD diagnosis
Table 5 shows the sensitivity, specificity, PPV and NPV of
the optimal IEL lymphogram (total, cd, and CD3- IELs
counts) for active and silent CD diagnosis.
In this study, the optimal IEL lymphogram for silent CD
diagnosis (total IELs C11 %, cd IELs C10 % and CD3-
IELs B5 %) had higher sensitivity, specificity and NPV
than the IEL lymphogram for active CD diagnosis (total
IELs C10 %, cd IELs C15 % and CD3- IELs B9 %).
However, the PPV of IEL lymphogram was higher for
active CD than for silent CD diagnosis (52 vs. 44 %).
Discussion
CD is an immune-mediated enteropathy caused by an
abnormal immune response to dietary gluten proteins,
characterized by altered IELs pattern.
Camarero et al. [13] have developed a FCM technique
for the evaluation of IELs subsets in intestinal biopsies of
CD patients. Three main alterations have been described in
CD patients. First, total IELs are increased during the
active phases of the disease [3–6, 18]. Second, which could
be considered practically pathognomonic, there is a per-
manent increase in cd IELs [19, 20], observed in every
form of the disease [8, 13, 21], and it could constitute the
first sign of latent or potential forms of CD [9]. Finally,
there is a pronounced and constant decrease in CD3- IELs,
which become virtually undetectable in active CD
[12, 23–25]. Since those changes in IEL subsets are very
characteristic of CD, the analysis by FCM of the 3
parameters (total, cd and CD3- IELs), and termed ‘‘IEL
Table 4 Serological markers in
children and adult celiac disease
AGA IgA?a TTG IgA?b AGA IgA? and TTG IgA?
Children (\18 years)
Active celiac disease 77 (33/43) 91 (39/43) 70 (30/43)
Silent celiac disease 67 (2/3) 100 (3/3) 67 (2/3)
Absent celiac disease 0 (0/13) 0 (0/13) 0 (0/13)
Adult (C18 years)
Active celiac disease 64 (7/11) 73 (8/11) 55 (6/11)
Silent celiac disease 59 (10/17) 65 (11/17) 53 (9/17)
Absent celiac disease 0 (0/143) 0 (0/143) 0 (0/143)
Data are expressed as percentage (number of positive cases/total number of cases)
AGA IgA anti-gliadin IgA antibodies, TTG IgA anti-recombinant human tissue transglutaminase IgA
a AGA IgA? C 20 UI/L
b TTG IgA? C 4 UI/L
Table 5 Diagnostic value of
optimal IEL lymphogram for









Optimal IEL lymphogram in active CD
(C10, C15 and B9 %)
45 86 52 82
Optimal IEL lymphogram in silent CD
(C11, C10 and B5 %)
56 92 44 95
IEL lymphogram: total, cd and CD3– IELs
IEL intraepithelial lymphocytes, CD celiac disease, PPV positive predictive value, NPV negative predictive
value
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lymphogram’’ has been described to be of high specificity
and sensitivity in the diagnosis of CD, even of atypical
forms [6].
In this study we have evaluated the profile of IELs in a
long cohort of patients with active and silent CD.
According to other authors, we have also found a signifi-
cant increase of both total and cd IELs and a significant
decrease of CD3- IELs in active CD patients as compared
to patients with absent CD [13, 16, 19, 22, 26]. Interest-
ingly, we have observed similar alterations on IELs subsets
in silent CD patients. Our results are in discordance with
the study of Erias et al. [27] that reported the same IEL
lymphograms in patients with active, latent and potential
CD, and suggested that the IELs lymphogram may be
particularly useful for the diagnosis of latent and potential
CD. In the same way, Goldstein et al. [28] suggested that
increased IELs could constitute, by themselves, the first
sign of latent or potential forms of CD, even in the pres-
ence of preserved villi. Moreover, several authors reported
that potential CD was characterized by an increased num-
ber of total and/or cd IELs [9, 13, 21, 27]. From our data,
the evaluation of the IELs subsets may be of help as
diagnostic tool in active and silent CD, but we do not have
conclusive data on potential CD.
Besides, we have compared the IELs subsets in children
and adults active CD patients. Accordingly with the study
of Calleja et al. [26], we have also found more pronounced
changes on IELs subsets in children than in adult active CD
patients, suggesting that the determination of IELs subsets
may be particularly useful for the diagnosis of active CD in
children.
Of note, we have observed that the increase of total and
cd IELs was higher in active CD patients with severe
histopathology than in those with mild histopathology.
Moreover, we have found that as serum levels of TTG IgA
increase there is a linear tendency toward more severe
histopathological lesions and higher cd IELs counts. These
data are in agreement with previous reports [29–32], which
described that TTG IgA levels are correlated with the
degree of histopathological lesions in CD patients. How-
ever, our results are in disagreement with previous studies
[8, 13, 21, 26], which reported that the density of cd IELs
was not correlated with the degree of intestinal tissue
damage and that there was an increase on the density of cd
IELs in all stages of CD, including latent and potential CD
patients. These authors suggest that the evaluation of cd
IELs could be used as a diagnostic marker to identify early
stage CD. Our data may reflect that in patients with more
active disease, represented by more severe histopathology
and higher levels of TTG IgA, there are more abnormalities
in IELs subsets, mainly cd IELs.
Finally, the optimal IEL lymphogram set in the present
study for silent CD diagnosis (total IELs C11 %, cd IELs
C10 % and CD3- IELs B5 %) had better diagnostic per-
formance than that set for active CD diagnosis (total IELs
C10 %, cd IELs C15 % and CD3- IELs B9 %).
In conclusion, our results indicate that the evaluation of
IELs subsets by FCM could be useful to confirm diagnosis
of active and silent CD.
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